Spearheaded by the France Alzheimer’s association, the 22nd edition of the World Day to combat Alzheimer’s Disease will take place on Monday 21 September. The focus this year will be on Alzheimer’s sufferers’ speech.
Since its creation, Inserm has made Alzheimer’s disease one of its priorities. Each year, this neurodegenerative disorder, which results in progressive and permanent deterioration of the nerve cells, engages many teams in the development of new treatments.
Bruno Dubois, Director of the Institute for Memory and Alzheimer’s Disease and Director of the “Cognition, Imaging and Brain Disorders” team notably work on the reasons for the development and progression of the disease through the INSIGHT study.
Furthermore, Inserm, in particular Hervé Platel and his team in Inserm Unit 1077, are dedicating part of their research to the study and benefit of music therapy to help people affected by Alzheimer’s Disease. For further information, see the series of films “Alzheimer’s Allegros” on the Inserm site.